We are performing website maintenance today from 8 a.m. - 5  p.m. PT, and some features may become unavailable intermittently. We apologize for any inconvenience.

  • Medicare Part B Spending and Anti-VEGF Drugs

    Written By: Jean Shaw
    Selected By: Andrew P. Schachat, MD

    Patel set out to tally the annual Medicare Part B costs associated with anti–vascular endothelial growth factor medications used by ophthalmologists.